{"id":524,"date":"2022-10-05T06:14:15","date_gmt":"2022-10-05T06:14:15","guid":{"rendered":"https:\/\/mebicar.pl\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/"},"modified":"2022-10-22T17:33:24","modified_gmt":"2022-10-22T17:33:24","slug":"pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg","status":"publish","type":"product","link":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/","title":{"rendered":"Pramiracetam purity of substance \u2265 99% 1000mg."},"content":{"rendered":"<h1 id=\"firstHeading\" class=\"firstHeading mw-first-heading\"><span class=\"mw-page-title-main\">Pramiracetam<\/span><\/h1>\n<ul>\n<li>\n<h5>Cas No. : 68497-62-1<\/h5>\n<\/li>\n<li>\n<h5>Purity of Pramiracetam \u2265 99% by net weight.<\/h5>\n<\/li>\n<li>\n<h5>Net weight: 1000mg<\/h5>\n<\/li>\n<li>\n<h5>Molecular Formula: C14H27N3O2<\/h5>\n<\/li>\n<li>\n<h5>Molar mass: 269.389 g-mol-1<\/h5>\n<\/li>\n<li>\n<h5>Use: Product for laboratory testing only, not for consumption.<\/h5>\n<\/li>\n<li>\n<h5>Form: pure crystalline substance in powder form.<\/h5>\n<\/li>\n<\/ul>\n<h2>\n&#13;\n<p>\u00a0<\/p>&#13;\n<p>Pramiracetam jest stymulantem o\u015brodkowego uk\u0142adu nerwowego. Jest \u015brodkiem nootropowym nale\u017c\u0105cym do rodziny lek\u00f3w nazywanych\u00a0 racetamami. Jest sprzedawany przez firm\u0119 Menarini pod mark\u0105 produktu Pramistar. S\u0142u\u017cy jako lek na popraw\u0119 pami\u0119ci. Znajduje zastosowanie szczeg\u00f3lnie u starzej\u0105cych si\u0119 os\u00f3b u kt\u00f3rych zdiagnozowano chorob\u0119 neurodegeneracyjn\u0105.<\/p>&#13;\n<p>Pramiracetam zosta\u0142 odkryty i zbadnany przez naukowc\u00f3w z Parke-Davis, mia\u0142o to miejsce pod koniec lat siedemdziesi\u0105tych. Prawa patentowe na pramiracetam wygas\u0142y w 1996 roku. Warner-Lambert przeprowadzi\u0142 szereg bada\u0144 klinicznych z u\u017cyciem pramiracetamu. Badania zosta\u0142y przeprowadzone na osobach ze schorzeniem Alzheimera. Badania nad pramiracetamem zosta\u0142y zaprzesatane ze wzgl\u0119du na niejednoznaczne wyniki. Dalsz\u0105 faz\u0105 rozwojow\u0105 by\u0142o opracowanie moleku\u0142y jako dodatek do terapii elektrowstrz\u0105sowej. Badania by\u0142y skoncentrowane na leczeniu powa\u017cnych zaburze\u0144 depresyjnych. Moleku\u0142\u0119 pramiracetamu przej\u0105\u0142 Cambridge Neuroscience, Inc (CNI), kt\u00f3ra realizowa\u0142a wskazanie do zastosowania substancji do terapii elektrowstrz\u0105sami, a tak\u017ce do stosowania w przywracaniu funkcji poznawczych. Badania mierzy\u0142y w pomoc pacjentom po udarze oraz u kt\u00f3rych dosz\u0142o do fizycznego uszkodzenia m\u00f3zgu.<\/p>&#13;\n<p>CNI przeprowadzi\u0142o ma\u0142oskalowe badanie kliniczne na czterech osobach, kt\u00f3re mia\u0142y problemy kognitywne po urazie g\u0142owy. Badania przeprowadzone przez lub w imieniu Menarini i Warner-Lambert obejmowa\u0142y dwa niewielkie badania przeprowadzone na Ukrainie. Jedno badanie na osobach z chorob\u0105 naczy\u0144 m\u00f3zgowych, a drugie na osobach ze wstrz\u0105sem m\u00f3zgu. Kolejne poszlakowe badanie w zastosowaniu pramiracetamu przeprowadzono we W\u0142oszech na zdrowych ludziach. W badaniu u\u017cyto skopolaminy aby indukowa\u0107 u pacjent\u00f3w amnezj\u0119 a pramiracetam mia\u0142 za zadadnie redukcj\u0119 skutk\u00f3w dysocjacji.\u00a0<\/p>&#13;\n<p>Sprzedawany pramiracetam s\u0142u\u017cy wy\u0142\u0105cznie do bada\u0144 labolatoryjnych!<\/p>&#13;\n<p>\u00a0<\/p>&#13;\n<p>Wi\u0119cej szczeg\u00f3\u0142\u00f3w w artykule naukowym dotyczacym moleku\u0142y Pramiracetam:<\/p>&#13;\n<p><blockquote class=\"wp-embedded-content\" data-secret=\"f0jkiAxVmx\"><a href=\"https:\/\/mebicar.pl\/pramiracetam-doping-dla-mozgu\/\">Pramiracetam &#8211; doping dla m\u00f3zgu<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Pramiracetam &#8211; doping dla m\u00f3zgu&#8221; &#8212; NONSENSIA, Laboratorium.\" src=\"https:\/\/mebicar.pl\/pramiracetam-doping-dla-mozgu\/embed\/#?secret=SvZJPLYpc8#?secret=f0jkiAxVmx\" data-secret=\"f0jkiAxVmx\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>&#13;\n<p>\u00a0<\/p>&#13;\n<p>Referencje Naukowe:<\/p>&#13;\n<ol class=\"references\">&#13;\n<li id=\"cite_note-1\">\u00a0<span class=\"reference-text\">AIFA\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/farmaco?farmaco=028021\" rel=\"nofollow\">Pramistar authorizations in the Agenzia Italiana del Farmaco Database<\/a>\u00a0Page accessed August 2, 2015.\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_000211_028021_FI.pdf&amp;retry=0&amp;sys=m0b1l3\" rel=\"nofollow\">Italian Label<\/a>, linked from that site]<\/span><\/li>&#13;\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-2\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">Drugs.com\u00a0<a class=\"external text\" href=\"https:\/\/www.drugs.com\/international\/pramiracetam.html\" rel=\"nofollow\">Drugs.com International listings for pramiracetam<\/a>\u00a0Page accessed August 2, 2015<\/span><\/li>&#13;\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-3\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">Italian marketing authorization for the brand name Remen has been revoked per the\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/farmaco?farmaco=027908\" rel=\"nofollow\">AIFA database<\/a>, as has the marketing authorization for the brand name Neupramir, per the\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/farmaco?farmaco=028029\" rel=\"nofollow\">AIFA database<\/a>, each checked on August 2, 2015. Main page at AIFA for pramiracetam is\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/cerca-per-principio-attivo?princ_att=Pramiracetam\" rel=\"nofollow\">here<\/a><\/span><\/li>&#13;\n<li id=\"cite_note-Pink-4\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-Pink_4-0\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">Staff, The Pink Sheet. May 27, 1991\u00a0<a class=\"external text\" href=\"https:\/\/www.pharmamedtechbi.com\/publications\/the-pink-sheet\/53\/021\/cambridge-neuroscience-developing-warnerlamberts-pramiracetam\" rel=\"nofollow\">Cambridge Neuroscience Developing Warner-Lambert&#8217;s Pramiracetam<\/a><\/span><\/li>&#13;\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-5\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">FDA\u00a0<a class=\"external text\" href=\"http:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/OOPD_Results_2.cfm?Index_Number=061691\" rel=\"nofollow\">Orphan Drug Designations and Approvals Database<\/a>\u00a0Page accessed August 2, 2015<\/span><\/li>&#13;\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-6\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\"><cite id=\"CITEREFMalykhSadaie2010\" class=\"citation journal cs1\">Malykh AG, Sadaie MR (February 2010). &#8220;Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders&#8221;.\u00a0<i>Drugs<\/i>.\u00a0<b>70<\/b>\u00a0(3): 287\u2013312.\u00a0<a class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\">doi<\/a>:<a class=\"external text\" href=\"https:\/\/doi.org\/10.2165%2F11319230-000000000-00000\" rel=\"nofollow\">10.2165\/11319230-000000000-00000<\/a>.\u00a0<a class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\">PMID<\/a>\u00a0<a class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20166767\" rel=\"nofollow\">20166767<\/a>.<\/cite><\/span><\/li>&#13;\n<li>https:\/\/examine.com\/supplements\/pramiracetam\/#examine-database<\/li>&#13;\n<\/ol>&#13;\n<h1 id=\"firstHeading\" class=\"firstHeading mw-first-heading wp-block-heading\"><span class=\"mw-page-title-main\">Pramiracetam<\/span><\/h1>&#13;\n<ul>&#13;\n<li>&#13;\n<h5>Cas No. : 68497-62-1<\/h5>&#13;\n<\/li>&#13;\n<li>&#13;\n<h5>Purity of Pramiracetam \u2265 99% by net weight.<\/h5>&#13;\n<\/li>&#13;\n<li>&#13;\n<h5>Net weight: 1000mg<\/h5>&#13;\n<\/li>&#13;\n<li>&#13;\n<h5>Molecular Formula: C14H27N3O2<\/h5>&#13;\n<\/li>&#13;\n<li>&#13;\n<h5>Molar mass: 269.389 g-mol-1<\/h5>&#13;\n<\/li>&#13;\n<li>&#13;\n<h5>Use: Product for laboratory testing only, not for consumption.<\/h5>&#13;\n<\/li>&#13;\n<li>&#13;\n<h5>Form: pure crystalline substance in powder form.<\/h5>&#13;\n<\/li>&#13;\n<\/ul>&#13;\n<h2><\/h2>&#13;\n<p>\u00a0<\/p>&#13;\n<p>Pramiracetam jest stymulantem o\u015brodkowego uk\u0142adu nerwowego. Jest \u015brodkiem nootropowym nale\u017c\u0105cym do rodziny lek\u00f3w nazywanych\u00a0 racetamami. Jest sprzedawany przez firm\u0119 Menarini pod mark\u0105 produktu Pramistar. S\u0142u\u017cy jako lek na popraw\u0119 pami\u0119ci. Znajduje zastosowanie szczeg\u00f3lnie u starzej\u0105cych si\u0119 os\u00f3b u kt\u00f3rych zdiagnozowano chorob\u0119 neurodegeneracyjn\u0105.<\/p>&#13;\n<p>Pramiracetam zosta\u0142 odkryty i zbadnany przez naukowc\u00f3w z Parke-Davis, mia\u0142o to miejsce pod koniec lat siedemdziesi\u0105tych. Prawa patentowe na pramiracetam wygas\u0142y w 1996 roku. Warner-Lambert przeprowadzi\u0142 szereg bada\u0144 klinicznych z u\u017cyciem pramiracetamu. Badania zosta\u0142y przeprowadzone na osobach ze schorzeniem Alzheimera. Badania nad pramiracetamem zosta\u0142y zaprzesatane ze wzgl\u0119du na niejednoznaczne wyniki. Dalsz\u0105 faz\u0105 rozwojow\u0105 by\u0142o opracowanie moleku\u0142y jako dodatek do terapii elektrowstrz\u0105sowej. Badania by\u0142y skoncentrowane na leczeniu powa\u017cnych zaburze\u0144 depresyjnych. Moleku\u0142\u0119 pramiracetamu przej\u0105\u0142 Cambridge Neuroscience, Inc (CNI), kt\u00f3ra realizowa\u0142a wskazanie do zastosowania substancji do terapii elektrowstrz\u0105sami, a tak\u017ce do stosowania w przywracaniu funkcji poznawczych. Badania mierzy\u0142y w pomoc pacjentom po udarze oraz u kt\u00f3rych dosz\u0142o do fizycznego uszkodzenia m\u00f3zgu.<\/p>&#13;\n<p>CNI przeprowadzi\u0142o ma\u0142oskalowe badanie kliniczne na czterech osobach, kt\u00f3re mia\u0142y problemy kognitywne po urazie g\u0142owy. Badania przeprowadzone przez lub w imieniu Menarini i Warner-Lambert obejmowa\u0142y dwa niewielkie badania przeprowadzone na Ukrainie. Jedno badanie na osobach z chorob\u0105 naczy\u0144 m\u00f3zgowych, a drugie na osobach ze wstrz\u0105sem m\u00f3zgu. Kolejne poszlakowe badanie w zastosowaniu pramiracetamu przeprowadzono we W\u0142oszech na zdrowych ludziach. W badaniu u\u017cyto skopolaminy aby indukowa\u0107 u pacjent\u00f3w amnezj\u0119 a pramiracetam mia\u0142 za zadadnie redukcj\u0119 skutk\u00f3w dysocjacji.\u00a0<\/p>&#13;\n<p>Sprzedawany pramiracetam s\u0142u\u017cy wy\u0142\u0105cznie do bada\u0144 labolatoryjnych!<\/p>&#13;\n<p>\u00a0<\/p>&#13;\n<p>Wi\u0119cej szczeg\u00f3\u0142\u00f3w w artykule naukowym dotyczacym moleku\u0142y Pramiracetam:<\/p>&#13;\n<p><blockquote class=\"wp-embedded-content\" data-secret=\"f0jkiAxVmx\"><a href=\"https:\/\/mebicar.pl\/pramiracetam-doping-dla-mozgu\/\">Pramiracetam &#8211; doping dla m\u00f3zgu<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Pramiracetam &#8211; doping dla m\u00f3zgu&#8221; &#8212; NONSENSIA, Laboratorium.\" src=\"https:\/\/mebicar.pl\/pramiracetam-doping-dla-mozgu\/embed\/#?secret=SvZJPLYpc8#?secret=f0jkiAxVmx\" data-secret=\"f0jkiAxVmx\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>&#13;\n<p>\u00a0<\/p>&#13;\n<p>Referencje Naukowe:<\/p>&#13;\n<ol class=\"references\">&#13;\n<li id=\"cite_note-1\">\u00a0<span class=\"reference-text\">AIFA\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/farmaco?farmaco=028021\" rel=\"nofollow\">Pramistar authorizations in the Agenzia Italiana del Farmaco Database<\/a>\u00a0Page accessed August 2, 2015.\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_000211_028021_FI.pdf&amp;retry=0&amp;sys=m0b1l3\" rel=\"nofollow\">Italian Label<\/a>, linked from that site]<\/span><\/li>&#13;\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-2\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">Drugs.com\u00a0<a class=\"external text\" href=\"https:\/\/www.drugs.com\/international\/pramiracetam.html\" rel=\"nofollow\">Drugs.com International listings for pramiracetam<\/a>\u00a0Page accessed August 2, 2015<\/span><\/li>&#13;\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-3\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">Italian marketing authorization for the brand name Remen has been revoked per the\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/farmaco?farmaco=027908\" rel=\"nofollow\">AIFA database<\/a>, as has the marketing authorization for the brand name Neupramir, per the\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/farmaco?farmaco=028029\" rel=\"nofollow\">AIFA database<\/a>, each checked on August 2, 2015. Main page at AIFA for pramiracetam is\u00a0<a class=\"external text\" href=\"https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/cerca-per-principio-attivo?princ_att=Pramiracetam\" rel=\"nofollow\">here<\/a><\/span><\/li>&#13;\n<li id=\"cite_note-Pink-4\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-Pink_4-0\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">Staff, The Pink Sheet. May 27, 1991\u00a0<a class=\"external text\" href=\"https:\/\/www.pharmamedtechbi.com\/publications\/the-pink-sheet\/53\/021\/cambridge-neuroscience-developing-warnerlamberts-pramiracetam\" rel=\"nofollow\">Cambridge Neuroscience Developing Warner-Lambert&#8217;s Pramiracetam<\/a><\/span><\/li>&#13;\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-5\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\">FDA\u00a0<a class=\"external text\" href=\"http:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/OOPD_Results_2.cfm?Index_Number=061691\" rel=\"nofollow\">Orphan Drug Designations and Approvals Database<\/a>\u00a0Page accessed August 2, 2015<\/span><\/li>&#13;\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pramiracetam#cite_ref-6\" aria-label=\"Jump up\">^<\/a><\/b><\/span>\u00a0<span class=\"reference-text\"><cite id=\"CITEREFMalykhSadaie2010\" class=\"citation journal cs1\">Malykh AG, Sadaie MR (February 2010). &#8220;Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders&#8221;.\u00a0<i>Drugs<\/i>.\u00a0<b>70<\/b>\u00a0(3): 287\u2013312.\u00a0<a class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\">doi<\/a>:<a class=\"external text\" href=\"https:\/\/doi.org\/10.2165%2F11319230-000000000-00000\" rel=\"nofollow\">10.2165\/11319230-000000000-00000<\/a>.\u00a0<a class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\">PMID<\/a>\u00a0<a class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20166767\" rel=\"nofollow\">20166767<\/a>.<\/cite><\/span><\/li>&#13;\n<li>https:\/\/examine.com\/supplements\/pramiracetam\/#examine-database<\/li>&#13;\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent has been tested on patients with brain injuries. One of the few molecules that has been tested on patients with physical brain injuries.<\/p>\n","protected":false},"featured_media":953,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_cat":[164],"product_tag":[165,170,169,167,166,168],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pramiracetam purity of substance \u2265 99% 1000mg. - NONSENSIA, Laboratorium.<\/title>\n<meta name=\"description\" content=\"Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent was tested on patients with brain injuries\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pramiracetam purity of substance \u2265 99% 1000mg. - NONSENSIA, Laboratorium.\" \/>\n<meta property=\"og:description\" content=\"Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent was tested on patients with brain injuries\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/\" \/>\n<meta property=\"og:site_name\" content=\"NONSENSIA, Laboratorium.\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-22T17:33:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mebicar.pl\/wp-content\/uploads\/2022\/10\/Pramiracetam_Kup_Shop_Online-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2387\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/\",\"url\":\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/\",\"name\":\"Pramiracetam purity of substance \u2265 99% 1000mg. - NONSENSIA, Laboratorium.\",\"isPartOf\":{\"@id\":\"https:\/\/mebicar.pl\/#website\"},\"datePublished\":\"2022-10-05T06:14:15+00:00\",\"dateModified\":\"2022-10-22T17:33:24+00:00\",\"description\":\"Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent was tested on patients with brain injuries\",\"breadcrumb\":{\"@id\":\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/mebicar.pl\/en\/shop-2\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sklep\",\"item\":\"https:\/\/mebicar.pl\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pramiracetam purity of substance \u2265 99% 1000mg.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mebicar.pl\/#website\",\"url\":\"https:\/\/mebicar.pl\/\",\"name\":\"NONSENSIA, Laboratorium.\",\"description\":\"Modafinil, Phenylpiracetam, Bromantane NOOTROPIKI!\",\"publisher\":{\"@id\":\"https:\/\/mebicar.pl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mebicar.pl\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mebicar.pl\/#organization\",\"name\":\"LAB\",\"url\":\"https:\/\/mebicar.pl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mebicar.pl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mebicar.pl\/wp-content\/uploads\/2022\/10\/Nonsensia_Go.png\",\"contentUrl\":\"https:\/\/mebicar.pl\/wp-content\/uploads\/2022\/10\/Nonsensia_Go.png\",\"width\":2133,\"height\":2133,\"caption\":\"LAB\"},\"image\":{\"@id\":\"https:\/\/mebicar.pl\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pramiracetam purity of substance \u2265 99% 1000mg. - NONSENSIA, Laboratorium.","description":"Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent was tested on patients with brain injuries","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/","og_locale":"en_US","og_type":"article","og_title":"Pramiracetam purity of substance \u2265 99% 1000mg. - NONSENSIA, Laboratorium.","og_description":"Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent was tested on patients with brain injuries","og_url":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/","og_site_name":"NONSENSIA, Laboratorium.","article_modified_time":"2022-10-22T17:33:24+00:00","og_image":[{"width":2387,"height":2560,"url":"https:\/\/mebicar.pl\/wp-content\/uploads\/2022\/10\/Pramiracetam_Kup_Shop_Online-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/","url":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/","name":"Pramiracetam purity of substance \u2265 99% 1000mg. - NONSENSIA, Laboratorium.","isPartOf":{"@id":"https:\/\/mebicar.pl\/#website"},"datePublished":"2022-10-05T06:14:15+00:00","dateModified":"2022-10-22T17:33:24+00:00","description":"Pramiracetam a molecule in the racetam family designed to reverse neurodegradative processes. The agent was tested on patients with brain injuries","breadcrumb":{"@id":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mebicar.pl\/en\/sklep\/pramiracetam-purity-of-substance-%e2%89%a5-99-1000mg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mebicar.pl\/en\/shop-2\/"},{"@type":"ListItem","position":2,"name":"Sklep","item":"https:\/\/mebicar.pl\/"},{"@type":"ListItem","position":3,"name":"Pramiracetam purity of substance \u2265 99% 1000mg."}]},{"@type":"WebSite","@id":"https:\/\/mebicar.pl\/#website","url":"https:\/\/mebicar.pl\/","name":"NONSENSIA, Laboratorium.","description":"Modafinil, Phenylpiracetam, Bromantane NOOTROPIKI!","publisher":{"@id":"https:\/\/mebicar.pl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mebicar.pl\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mebicar.pl\/#organization","name":"LAB","url":"https:\/\/mebicar.pl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mebicar.pl\/#\/schema\/logo\/image\/","url":"https:\/\/mebicar.pl\/wp-content\/uploads\/2022\/10\/Nonsensia_Go.png","contentUrl":"https:\/\/mebicar.pl\/wp-content\/uploads\/2022\/10\/Nonsensia_Go.png","width":2133,"height":2133,"caption":"LAB"},"image":{"@id":"https:\/\/mebicar.pl\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/product\/524"}],"collection":[{"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/comments?post=524"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/media\/953"}],"wp:attachment":[{"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/media?parent=524"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/product_cat?post=524"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/mebicar.pl\/en\/wp-json\/wp\/v2\/product_tag?post=524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}